Steven E McKenzie (Steven E Mckenzie)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Induced Pluripotent Stem Cells

Radiation Therapy

Pulmonary Embolism

Top Venues

Journal of thrombosis and haemostasis : JTH

Arteriosclerosis, thrombosis, and vascular biology

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Xu Han, Elizabeth A Knauss, Maria de la Fuente, Wei Li, Ronald A Conlon, David F LePage, Weihong Jiang, Stephanie A Renna, Steven E McKenzie, Marvin T Nieman
A Mouse Model of the Protease Activated Receptor 4 (PAR4) Pro310Leu Variant has Reduced Platelet Reactivity. bioRxiv : the preprint server for biology (2023)
Stephanie A Renna, Xuefei Zhao, Satya P Kunapuli, Peisong Ma, Michael A Holinstat, Matthew B Boxer, David J Maloney, James V Michael, Steven E McKenzie
Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition. Arteriosclerosis, thrombosis, and vascular biology (2023)
Steven E McKenzie
A vision for a quicker definitive diagnosis of HIT. Blood 140 (25) (2022)
Steven E McKenzie
A vision for a quicker definitive diagnosis of HIT. Blood 140 (25) (2022)
Rupsa C Boelig, Tara J Cahanap, Lin Ma, Tingting Zhan, Vincenzo Berghella, Joanna S Y Chan, Walter K Kraft, Steven E McKenzie
Platelet protease activated receptor 4 (PAR 4) receptor genotype is associated with an increased risk of preterm birth. Journal of thrombosis and haemostasis : JTH 20 (10) (2022)
Stephanie A Renna, James V Michael, Xianguo Kong, Lin Ma, Peisong Ma, Marvin T Nieman, Leonard C Edelstein, Steven E McKenzie
Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice. Journal of thrombosis and haemostasis : JTH 20 (5) (2022)
Steven E McKenzie
A vision for a quicker definitive diagnosis of HIT. Blood 140 (25) (2022)
Steven E McKenzie
Sugar and spike: not so nice. Blood 138 (16) (2021)